News/ News/ R&D Kintor hits back at press criticism of COVID drug with US trial update Richard Staines COVID-19, Kintor, proxalutamide, R&D 0 Comment The China-based biotech Kintor has hit back at press criticism of its potential COVID drug proxalutamide, releasing further Share X Kintor hits back at press criticism of COVID drug with US trial update https://pharmaphorum.com/news/kintor-hits-back-at-press-criticism-of-covid-drug-with-us-trial-update/
News/ News/ R&D Scepticism in press over Kintor’s COVID-19 US drug trial Richard Staines COVID-19, Kintor, proxalutamide, R&D 0 Comment China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there Share X Scepticism in press over Kintor’s COVID-19 US drug trial https://pharmaphorum.com/news/doubts-emerge-over-kintors-covid-19-us-drug-trial/
